Trends in neonatal morbidity and mortality for very low birthweight infants. 2007

Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
Department of Pediatrics, Case Western Reserve University, Cleveland, OH.

OBJECTIVE To document the mortality and morbidity of infants weighing 501-1500 g at birth according to gestational age, birthweight, and sex. METHODS Prospective collection of perinatal events and neonatal course to 120 days of life, discharge, or death from January 1990 through December 2002 for infants born at 16 participating centers of the National Institute of Child Health & Human Development Neonatal Research Network. RESULTS Compared with 1995-1996, for 1997-2002 the survival of infants with birthweight of 501-1500 g increased by 1 percentage point (from 84% to 85%). Survival without major neonatal morbidity remained static, at 70%; this includes bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and necrotizing enterocolitis (NEC). Survival increased for multiple births (26%, up from 22%), antenatal corticosteroid use (79%, up from 71%), and maternal antibiotics (70%, up from 62%) (P < .05). From 1997 to 2002, birthweight-specific survival was 55% for infants weighing 501-750 g, 88% for 751-1000 g, 94% for 1001-1250 g, and 96% for 1251-1500 g. More females survived. The incidence of NEC (7%), severe IVH (12%), and late-onset septicemia (22%) remained essentially unchanged, but BPD decreased slightly, from 23% to 22%. The use of postnatal corticosteroids declined from 20% in 1997-2000 to 12% in 2001-2002. Growth failure (weight <10th percentile) at 36 weeks' postmenstrual age decreased from 97% in 1995-1996 to 91% in 1997-2002. CONCLUSIONS There have been no significant increases in survival without neonatal and long-term morbidity among VLBW infants between 1997 and 2002. We speculate that to improve survival without morbidity requires determining, disseminating, and applying best practices using therapies currently available, and also identifying new strategies and interventions.

UI MeSH Term Description Entries
D007226 Infant Mortality Postnatal deaths from BIRTH to 365 days after birth in a given population. Postneonatal mortality represents deaths between 28 days and 365 days after birth (as defined by National Center for Health Statistics). Neonatal mortality represents deaths from birth to 27 days after birth. Neonatal Mortality,Mortality, Infant,Postneonatal Mortality,Infant Mortalities,Mortalities, Infant,Mortalities, Neonatal,Mortalities, Postneonatal,Mortality, Neonatal,Mortality, Postneonatal,Neonatal Mortalities,Postneonatal Mortalities
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D009017 Morbidity The proportion of patients with a particular disease during a given year per given unit of population. Morbidities
D005260 Female Females
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
December 2023, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
January 1983, Pediatric annals,
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
October 1984, Archives of disease in childhood,
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
April 1989, Lancet (London, England),
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
June 1989, Lancet (London, England),
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
April 1989, Lancet (London, England),
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
March 1989, Lancet (London, England),
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
January 2000, The Cochrane database of systematic reviews,
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
January 2002, The Cochrane database of systematic reviews,
Avroy A Fanaroff, and Barbara J Stoll, and Linda L Wright, and Waldemar A Carlo, and Richard A Ehrenkranz, and Ann R Stark, and Charles R Bauer, and Edward F Donovan, and Sheldon B Korones, and Abbot R Laptook, and James A Lemons, and William Oh, and Lu-Ann Papile, and Seetha Shankaran, and David K Stevenson, and Jon E Tyson, and W Kenneth Poole, and
July 1985, British medical journal (Clinical research ed.),
Copied contents to your clipboard!